PeterPRoy-ByrneMD
Psychiatry • Seattle, WAPsychosomatic Medicine
Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington.
Dr. Roy-Byrne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Psychiatric Medicine Associates
1505 Westlake Ave N suite 920
Seattle, WA 98104Phone+1 206-386-3103Fax+1 206-386-3123
Education & Training
National Institutes of Health Clinical CenterResidency, Psychiatry, 1982 - 1985
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 1979 - 1982
Steward Carney HospitalInternship, Internal Medicine, 1978 - 1979
Tufts University School of MedicineClass of 1978
Certifications & Licensure
CA State Medical License 1979 - Present
WA State Medical License 1986 - 2025
MD State Medical License 1982 - 1987- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Women's Health Castle Connolly, 2008
Clinical Trials
- Primary Care Intervention Strategy for Anxiety Disorders Start of enrollment: 2006 Jun 01
- Brief Intervention in Primary Care for Problem Drug Use and Abuse Start of enrollment: 2009 Apr 01
Publications & Presentations
PubMed
- 52 citationsPlacebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder.Michael H. Kronig, Jeffrey T. Apter, Gregory M. Asnis, Alexander Bystritsky, George C. Curtis
Journal of Clinical Psychopharmacology. 1999-04-01 - 68 citationsPost-traumatic stress disorder among patients with chronic pain and chronic fatigue.Peter Roy-Byrne, Wayne R. Smith, Jack Goldberg, Niloofar Afari, Dedra Buchwald
Psychological Medicine. 2004-03-01 - 305 citationsDelivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial.Peter Roy-Byrne, Michelle G. Craske, Greer Sullivan, Raphael D. Rose, Mark J. Edlund
JAMA. 2010-05-19
Other
- Pharmacotherapy for panic disorderRoy-Byrne PP
http://www.uptodate.com/contents/pharmacotherapy-for-panic-disorder
UpToDate, Wolters Kluwer Health - 2012-12-20 - Diagnosis of psychiatric and psychologic disorders in patients with cancerRoy-Byrne PP
http://www.uptodate.com/contents/diagnosis-of-psychiatric-and-psychologic-disorders-in-patients-with
UpToDate, Wolters Kluwer Health - 2012-07-10 - Management of psychiatric and psychologic disorders in patients with cancerRoy-Byrne PP
http://www.uptodate.com/contents/management-of-psychiatric-and-psychologic-disorders-in-patients-wit
UpToDate, Wolters Kluwer Health - 2011-12-30
Press Mentions
Novel Antidepressant Reduces Depression Symptoms in 2 WeeksSeptember 4th, 2019- Amphetamine Tied to Higher Psychosis Risk in Young People with ADHDMarch 21st, 2019
- FDA Panel Recommends Approving Nasal Spray for Resistant DepressionFebruary 14th, 2019
- Join now to see all
Grant Support
- Brief Intervention In Primary Care For Problem Drug Use And AbuseNational Institute On Drug Abuse2008–2011
- Improving Mental Health Care In Safety NET Medical SettingsNational Institute Of Mental Health2010
- Calm: Improving Primary Care OutcomesNational Institute Of Mental Health2005–2009
- Treating Anxiety In Public Sector Medical SettingsNational Institute Of Mental Health2003–2007
- Improving Care For Panic Disorder In Primary CareNational Institute Of Mental Health1999–2002
- Benzodiazepine Sensitivity In Human AnxietyNational Institute Of Mental Health1992–1993
- Benzodiazepine Sensitivity In Panic &General AnxietyNational Institute Of Mental Health1988–1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
